Mild to Moderate Alzheimer's Disease
Mild to Moderate Alzheimer's Disease is a progressive brain disorder that affects memory, thinking, and behavior. In this stage, individuals may experience confusion, memory loss, and difficulty with daily tasks.
Alzheimer's Disease: Rotigotine and Rivastigmine Study
We are testing a combination of rotigotine and rivastigmine to see if it improves thinking skills and daily activities in people with mild to moderate Alzheimer's disease. This study compares the new treatment to rivastigmine with a placebo.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 50 and 85 years old?
- Do you have a diagnosis of Alzheimer's disease (AD)?
- Are you currently taking any medications for heart problems, such as blood pressure medications or heart rhythm medications?
- Do you have any major health issues like severe liver disease, kidney disease, or uncontrolled diabetes?
- Are you currently experiencing major depression or other serious mental health issues?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Dariante
Rotigotin Gebro
Rotigotin Luye
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
NeuropsychiatrieHK s.r.o.
NeuropsychiatrieHK
Hradec Králové, Czechia
Psychiatrie-ambulance s.r.o.
Psychiatrie-ambulance
Pilsen, Czechia
Vestra Clinics s.r.o.
Vestra Clinics
Rychnov nad Kněžnou, Czechia
Sponsor: Fondazione Santa Lucia IRCCS
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.